Identification and characterization of functional angiotensin II receptors in human neuroblastoma cells. 1995

M Maggi, and G Finetti, and A Cioni, and R Mancina, and E Baldi, and M Serio, and R M Catalioto, and A R Renzetti
Department of Clinical Physiopathology, University of Florence, Italy.

The presence of specific AII receptors in 6 different human neuroblastoma cell lines was investigated using binding, cAMP and [Ca2+]i studies. We found high affinity (0.1 nM), low capacity ((1-2).10(3) sites/cell) binding sites for [125I](Sar-1,Ile-8)AII in one half of the cell lines studied. In the positive cell lines mathematical modeling of multiple competition curves among AII and analogs strongly indicated the presence of a homogenous class of sites, i.e., AT1 receptors. The presence of AT1 receptors was further substantiated by AII-induced inhibition of VIP-stimulated cAMP levels and by AII-evoked [Ca2+]i transient. The density of AT1 receptors in neuroblastoma cells was not affected by treatment with pertussis toxin and retinoic acid but was significantly increased by subacute treatment with VIP. In neuroblastoma cells, AII does not stimulate DNA synthesis, suggesting other roles rather than mitogenesis. Neuroblastoma cells represents an interesting model to investigate the function of AII in neural crest derived tissues.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D007700 Kinetics The rate dynamics in chemical or physical systems.
D009447 Neuroblastoma A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51) Neuroblastomas
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D011945 Receptors, Angiotensin Cell surface proteins that bind ANGIOTENSINS and trigger intracellular changes influencing the behavior of cells. Angiotensin Receptor,Angiotensin Receptors,Angiotensin II Receptor,Angiotensin III Receptor,Receptor, Angiotensin II,Receptor, Angiotensin III,Receptor, Angiotensin
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000242 Cyclic AMP An adenine nucleotide containing one phosphate group which is esterified to both the 3'- and 5'-positions of the sugar moiety. It is a second messenger and a key intracellular regulator, functioning as a mediator of activity for a number of hormones, including epinephrine, glucagon, and ACTH. Adenosine Cyclic 3',5'-Monophosphate,Adenosine Cyclic 3,5 Monophosphate,Adenosine Cyclic Monophosphate,Adenosine Cyclic-3',5'-Monophosphate,Cyclic AMP, (R)-Isomer,Cyclic AMP, Disodium Salt,Cyclic AMP, Monoammonium Salt,Cyclic AMP, Monopotassium Salt,Cyclic AMP, Monosodium Salt,Cyclic AMP, Sodium Salt,3',5'-Monophosphate, Adenosine Cyclic,AMP, Cyclic,Adenosine Cyclic 3',5' Monophosphate,Cyclic 3',5'-Monophosphate, Adenosine,Cyclic Monophosphate, Adenosine,Cyclic-3',5'-Monophosphate, Adenosine,Monophosphate, Adenosine Cyclic

Related Publications

M Maggi, and G Finetti, and A Cioni, and R Mancina, and E Baldi, and M Serio, and R M Catalioto, and A R Renzetti
February 1986, The Journal of pharmacology and experimental therapeutics,
M Maggi, and G Finetti, and A Cioni, and R Mancina, and E Baldi, and M Serio, and R M Catalioto, and A R Renzetti
October 2001, Molecular and cellular endocrinology,
M Maggi, and G Finetti, and A Cioni, and R Mancina, and E Baldi, and M Serio, and R M Catalioto, and A R Renzetti
January 1996, Advances in experimental medicine and biology,
M Maggi, and G Finetti, and A Cioni, and R Mancina, and E Baldi, and M Serio, and R M Catalioto, and A R Renzetti
April 2005, Peptides,
M Maggi, and G Finetti, and A Cioni, and R Mancina, and E Baldi, and M Serio, and R M Catalioto, and A R Renzetti
January 1990, Biochemical and biophysical research communications,
M Maggi, and G Finetti, and A Cioni, and R Mancina, and E Baldi, and M Serio, and R M Catalioto, and A R Renzetti
March 1982, Biochemical and biophysical research communications,
M Maggi, and G Finetti, and A Cioni, and R Mancina, and E Baldi, and M Serio, and R M Catalioto, and A R Renzetti
January 1992, Biochemical and biophysical research communications,
M Maggi, and G Finetti, and A Cioni, and R Mancina, and E Baldi, and M Serio, and R M Catalioto, and A R Renzetti
August 1997, The Journal of urology,
M Maggi, and G Finetti, and A Cioni, and R Mancina, and E Baldi, and M Serio, and R M Catalioto, and A R Renzetti
December 1993, Circulation,
M Maggi, and G Finetti, and A Cioni, and R Mancina, and E Baldi, and M Serio, and R M Catalioto, and A R Renzetti
April 1993, Metabolism: clinical and experimental,
Copied contents to your clipboard!